|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2004-11-23
|
|
pubmed:abstractText |
Tuberculosis is responsible for >2 million deaths a year, and the number of new cases is rising worldwide. DNA vaccination combined with Mycobacterium bovis bacillus Calmette Guerin (BCG) represents a potential strategy for prevention of this disease. Here, we used a heterologous prime-boost immunization approach using a combination of DNA plasmids and BCG in order to improve the efficacy of vaccination against Mycobacterium tuberculosis infection in mice. As model antigens, we selected the M. tuberculosis Apa (for alanine-proline-rich antigen) and the immunodominant Hsp65 and Hsp70 mycobacterial antigens combined with BCG. We demonstrated that animals injected with a combination of DNA vectors expressing these antigens, when boosted with BCG, showed increased specific antimycobacterial immune responses compared to animals vaccinated with BCG alone. More importantly, the protection achieved with this regimen was also significantly better than with BCG alone.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-10517722,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-10531201,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-10542234,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-11095745,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-11349095,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-11905811,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-12218165,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-12531337,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-12654810,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-12692540,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-12874255,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-12933831,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-1347338,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-326347,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-7822025,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-8423100,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-8570663,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-8705858,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-9041939,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-9234527,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15557616-9560270
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/BCG Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Chaperonin 60,
http://linkedlifedata.com/resource/pubmed/chemical/Chaperonins,
http://linkedlifedata.com/resource/pubmed/chemical/HSP70 Heat-Shock Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/HSP70 protein, Mycobacterium...,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Mycobacterium tuberculosis antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, DNA,
http://linkedlifedata.com/resource/pubmed/chemical/heat-shock protein 65, Mycobacterium
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0019-9567
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
72
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6945-50
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:15557616-Animals,
pubmed-meshheading:15557616-Antigens, Bacterial,
pubmed-meshheading:15557616-BCG Vaccine,
pubmed-meshheading:15557616-Bacterial Proteins,
pubmed-meshheading:15557616-CD4-Positive T-Lymphocytes,
pubmed-meshheading:15557616-CD8-Positive T-Lymphocytes,
pubmed-meshheading:15557616-Chaperonin 60,
pubmed-meshheading:15557616-Chaperonins,
pubmed-meshheading:15557616-Female,
pubmed-meshheading:15557616-HSP70 Heat-Shock Proteins,
pubmed-meshheading:15557616-Immunization, Secondary,
pubmed-meshheading:15557616-Interferon-gamma,
pubmed-meshheading:15557616-Mice,
pubmed-meshheading:15557616-Mice, Inbred BALB C,
pubmed-meshheading:15557616-Mice, Inbred C57BL,
pubmed-meshheading:15557616-Tuberculosis,
pubmed-meshheading:15557616-Vaccines, DNA
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.
|
|
pubmed:affiliation |
The National Institute for Medical Research, Mill Hill, London NW7 1AA, United Kingdom. tricard@nimr.mrc.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
